Growth Metrics

Eli Lilly (LLY) Asset Utilization Ratio (2016 - 2026)

Eli Lilly filings provide 18 years of Asset Utilization Ratio readings, the most recent being 0.63 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 8.2% to 0.63 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.63, a 8.2% increase, with the full-year FY2025 number at 0.68, up 8.02% from a year prior.
  • Asset Utilization Ratio hit 0.63 in Q1 2026 for Eli Lilly, up from 0.57 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.63 in Q1 2026 to a low of 0.54 in Q1 2023.
  • Median Asset Utilization Ratio over the past 5 years was 0.57 (2024), compared with a mean of 0.58.
  • Biggest five-year swings in Asset Utilization Ratio: grew 12.35% in 2022 and later decreased 11.94% in 2023.
  • Eli Lilly's Asset Utilization Ratio stood at 0.59 in 2022, then decreased by 4.93% to 0.56 in 2023, then rose by 4.28% to 0.58 in 2024, then decreased by 1.8% to 0.57 in 2025, then grew by 10.05% to 0.63 in 2026.
  • The last three reported values for Asset Utilization Ratio were 0.63 (Q1 2026), 0.57 (Q4 2025), and 0.55 (Q3 2025) per Business Quant data.